Therefore, strategies aiming to rescue the leptin–adiponectin balance, i.e., reverting the obesity-associated increased leptin levels and reduced adipokines levels, are of relevance for NAFLD treatment [24]; this will be further explored in Section 5. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.